Veracyte Operating Income 2012-2019 | VCYT

Veracyte operating income from 2012 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Veracyte Annual Operating Income
(Millions of US $)
2018 $-22
2017 $-27
2016 $-29
2015 $-33
2014 $-29
2013 $-23
2012 $-19
2011 $-15
Veracyte Quarterly Operating Income
(Millions of US $)
Q2 2019 $-3
Q1 2019 $-2
Q4 2018 $-3
Q3 2018 $-4
Q2 2018 $-6
Q1 2018 $-9
Q4 2017 $-6
Q3 2017 $-6
Q2 2017 $-7
Q1 2017 $-8
Q4 2016 $-4
Q3 2016 $-5
Q2 2016 $-10
Q1 2016 $-10
Q4 2015 $-8
Q3 2015 $-9
Q2 2015 $-9
Q1 2015 $-8
Q4 2014 $-8
Q3 2014 $-8
Q2 2014 $-7
Q1 2014 $-7
Q4 2013 $-6
Q3 2013 $-6
Q2 2013 $-5
Q1 2013 $-6
Q4 2012
Q3 2012 $-5
Q2 2012
Q4 2011
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.242B $0.092B
Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $110.591B 23.56
Intuitive Surgical (ISRG) United States $57.102B 49.94
Edwards Lifesciences (EW) United States $45.616B 44.40
IDEXX Laboratories (IDXX) United States $23.710B 59.48
Fresenius Medical Care AG KGaA (FMS) Germany $20.332B 13.47
Teleflex (TFX) United States $17.097B 36.29
Olympus (OCPNY) Japan $16.422B 0.00
DexCom (DXCM) United States $14.925B 221.19
SONOVA HOLDING (SONVY) Switzerland $14.694B 0.00
Hologic (HOLX) United States $13.486B 21.29
STERIS (STE) Ireland $12.935B 29.83
Sysmex ADR (SSMXY) Japan $12.564B 33.87
Varian Medical Systems (VAR) United States $9.921B 23.74
ABIOMED (ABMD) United States $8.758B 50.13
Masimo (MASI) United States $8.067B 48.95
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.219B 23.29
Penumbra (PEN) United States $5.052B 181.51
Globus Medical (GMED) United States $4.930B 31.29
Elekta AB (EKTAY) Sweden $4.803B 38.32
LivaNova (LIVN) United Kingdom $3.845B 29.32
Cantel Medical (CMD) United States $3.726B 37.80
Tandem Diabetes Care (TNDM) United States $3.446B 0.00
Wright Medical Group (WMGI) Netherlands $2.692B 236.11
Nihon Kohden (NHNKY) Japan $2.569B 25.85
Integer Holdings (ITGR) United States $2.530B 17.90
Nevro (NVRO) United States $2.494B 0.00
Glaukos (GKOS) United States $2.291B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.744B 32.35
Silk Road Medical (SILK) United States $1.247B 0.00
OPKO Health (OPK) United States $1.207B 0.00
Natus Medical (NTUS) United States $1.052B 24.51
Accelerate Diagnostics (AXDX) United States $0.997B 0.00
CryoLife (CRY) United States $0.990B 94.25
ORTHOFIX MEDICAL INC (OFIX) United States $0.975B 30.62
Tactile Systems Technology (TCMD) United States $0.968B 119.63
Luminex (LMNX) United States $0.929B 0.00
Inogen (INGN) United States $0.925B 22.68
Corindus Vascular Robotics (CVRS) United States $0.889B 0.00
Pacific Biosciences Of California (PACB) United States $0.881B 0.00
Mesa Laboratories (MLAB) United States $0.865B 39.95
Quotient (QTNT) Switzerland $0.731B 0.00
AngioDynamics (ANGO) United States $0.707B 23.13
AxoGen (AXGN) United States $0.601B 0.00
Intersect ENT (XENT) United States $0.517B 0.00
Si-Bone (SIBN) United States $0.480B 0.00
OrthoPediatrics (KIDS) United States $0.472B 0.00
ViewRay (VRAY) United States $0.437B 0.00
Fluidigm (FLDM) United States $0.437B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.376B 14.43
GenMark Diagnostics (GNMK) United States $0.373B 0.00
Alphatec Holdings (ATEC) United States $0.360B 0.00
Sientra (SIEN) United States $0.341B 0.00
Semler Scientific (SMLR) United States $0.312B 52.75
Accuray (ARAY) United States $0.249B 0.00
IRadimed (IRMD) United States $0.240B 39.87
CRH Medical (CRHM) Canada $0.231B 80.25
RTI Surgical (RTIX) United States $0.228B 34.33
TransEnterix (TRXC) United States $0.210B 0.00
SeaSpine Holdings (SPNE) United States $0.205B 0.00
Stereotaxis (STXS) United States $0.187B 0.00
Neuronetics (STIM) United States $0.185B 0.00
ConforMIS (CFMS) United States $0.128B 0.00
Sensus Healthcare (SRTS) United States $0.105B 0.00
Second Sight Medical Products (EYES) United States $0.101B 0.00
EDAP TMS S.A (EDAP) France $0.087B 0.00
Apollo Endosurgery (APEN) United States $0.072B 0.00
Ekso Bionics Holdings (EKSO) United States $0.064B 0.00
Spectral Diagnostics (EDTXF) Canada $0.062B 0.00
Helius Medical Technologies (HSDT) United States $0.056B 0.00
Vermillion (VRML) United States $0.053B 0.00
Electromed (ELMD) United States $0.044B 22.70
Xtant Medical Holdings (XTNT) United States $0.038B 0.00
T2 Biosystems (TTOO) United States $0.036B 0.00
Nuvectra (NVTR) United States $0.029B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.029B 0.00
Restoration Robotics (HAIR) United States $0.028B 0.00
ReWalk Robotics (RWLK) Israel $0.024B 0.00
Ra Medical Systems (RMED) United States $0.023B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Bioanalytical Systems (BASI) United States $0.022B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
Lianluo Smart (LLIT) China $0.015B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.39
OBALON THERPTCS (OBLN) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Dynatronics (DYNT) United States $0.011B 0.00
Avinger (AVGR) United States $0.011B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00